Play all audios:
ABSTRACT The TRIM family of genes is largely studied because of their roles in development, differentiation and host cell antiviral defenses; however, roles in cancer biology are emerging.
Loss of heterozygosity of the TRIM3 locus in ∼20% of human glioblastomas raised the possibility that this NHL-domain containing member of the TRIM gene family might be a mammalian tumor
suppressor. Consistent with this, reducing TRIM3 expression increased the incidence of and accelerated the development of platelet-derived growth factor -induced glioma in mice. Furthermore,
TRIM3 can bind to the cdk inhibitor p21WAF1/CIP1. Thus, we conclude that TRIM3 is a tumor suppressor mapping to chromosome 11p15.5 and that it might block tumor growth by sequestering p21
and preventing it from facilitating the accumulation of cyclin D1–cdk4. Access through your institution Buy or subscribe This is a preview of subscription content, access via your
institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Learn more Buy this
article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in
* Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS _TP53_: THE UNLUCKIEST OF GENES? Article Open access 23 October
2024 DEPTOR IS A DIRECT P53 TARGET THAT SUPPRESSES CELL GROWTH AND CHEMOSENSITIVITY Article Open access 12 November 2020 GFI1 UPREGULATES C-MYC EXPRESSION AND PROMOTES C-MYC-DRIVEN CELL
PROLIFERATION Article Open access 13 October 2020 REFERENCES * Huse JT, Holland EC . Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. _Nat
Rev Cancer_ 2010; 10: 319–331. Article CAS Google Scholar * Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A _et al_. Glioblastoma subclasses can be defined by activity
among signal transduction pathways and associated genomic alterations. _PloS one_ 2009; 4: e7752. Article Google Scholar * Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P _et
al_. An integrated genomic analysis of human glioblastoma multiforme. _Science_ 2008; 321: 1807–1812. Article CAS Google Scholar * Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y,
Wilkerson MD _et al_. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. _Cancer cell_ 2010;
17: 98–110. Article CAS Google Scholar * Vitucci M, Hayes DN, Miller CR . Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised
therapy. _Br J Cancer_ 2011; 104: 545–553. Article CAS Google Scholar * Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC _et al_. Self-renewal does not predict tumor
growth potential in mouse models of high-grade glioma. _Cancer cell_ 2012; 21: 11–24. Article CAS Google Scholar * Chen J, McKay RM, Parada LF . Malignant glioma: lessons from genomics,
mouse models, and stem cells. _Cell_ 2012; 149: 36–47. Article CAS Google Scholar * Boulay JL, Stiefel U, Taylor E, Dolder B, Merlo A, Hirth F . Loss of heterozygosity of TRIM3 in
malignant gliomas. _BMC cancer_ 2009; 9: 71. Article Google Scholar * Nisole S, Stoye JP, Saib A . TRIM family proteins: retroviral restriction and antiviral defence. _Nat Rev Microbiol_
2005; 3: 799–808. Article CAS Google Scholar * Hatakeyama S . TRIM proteins and cancer. _Nat Rev Cancer_ 2011; 11: 792–804. Article CAS Google Scholar * Wulczyn FG, Cuevas E, Franzoni
E, Rybak A . MiRNA need a TRIM regulation of miRNA activity by Trim-NHL proteins. _Adv Exp Med Biol_ 2010; 700: 85–105. Article CAS Google Scholar * Reichert H . _Drosophila_ neural stem
cells: cell cycle control of self-renewal, differentiation, and termination in brain development. _Results Probl Cell Differ_ 2011; 53: 529–546. Article CAS Google Scholar * Arama E,
Dickman D, Kimchie Z, Shearn A, Lev Z . Mutations in the beta-propeller domain of the _Drosophila_ brain tumor (brat) protein induce neoplasm in the larval brain. _Oncogene_ 2000; 19:
3706–3716. Article CAS Google Scholar * Betschinger J, Mechtler K, Knoblich JA . Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem
cells. _Cell_ 2006; 124: 1241–1253. Article CAS Google Scholar * Bowman SK, Rolland V, Betschinger J, Kinsey KA, Emery G, Knoblich JA . The tumor suppressors Brat and Numb regulate
transit-amplifying neuroblast lineages in Drosophila. _Dev Cell_ 2008; 14: 535–546. Article CAS Google Scholar * Lee CY, Wilkinson BD, Siegrist SE, Wharton RP, Doe CQ . Brat is a Miranda
cargo protein that promotes neuronal differentiation and inhibits neuroblast self-renewal. _Dev Cell_ 2006; 10: 441–449. Article CAS Google Scholar * Januschke J, Gonzalez C . Drosophila
asymmetric division, polarity and cancer. _Oncogene_ 2008; 27: 6994–7002. Article CAS Google Scholar * Bello B, Reichert H, Hirth F . The brain tumor gene negatively regulates neural
progenitor cell proliferation in the larval central brain of Drosophila. _Development_ 2006; 133: 2639–2648. Article CAS Google Scholar * Choksi SP, Southall TD, Bossing T, Edoff K, de
Wit E, Fischer BE _et al_. Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells. _Dev Cell_ 2006; 11: 775–789. Article CAS Google
Scholar * Herranz H, Hong X, Perez L, Ferreira A, Olivieri D, Cohen SM _et al_. The miRNA machinery targets Mei-P26 and regulates Myc protein levels in the Drosophila wing. _EMBO J_ 2010;
29: 1688–1698. Article CAS Google Scholar * Schwamborn JC, Berezikov E, Knoblich JA . The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural
progenitors. _Cell_ 2009; 136: 913–925. Article CAS Google Scholar * Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW _et al_. PTEN/PI3K/Akt pathway regulates the
side population phenotype and ABCG2 activity in glioma tumor stem-like cells. _Cell stem cell_ 2009; 4: 226–235. Article CAS Google Scholar * Charles N, Ozawa T, Squatrito M, Bleau AM,
Brennan CW, Hambardzumyan D _et al_. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. _Cell stem cell_ 2010; 6: 141–152.
Article CAS Google Scholar * Charles NA, Holland EC . TRRAP and the maintenance of stemness in gliomas. _Cell stem cell_ 2010; 6: 6–7. Article CAS Google Scholar * Dai C, Celestino JC,
Okada Y, Louis DN, Fuller GN, Holland EC . PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and
astrocytes _in vivo_. _Genes Dev_ 2001; 15: 1913–1925. Article CAS Google Scholar * Katz AM, Amankulor NM, Pitter K, Helmy K, Squatrito M, Holland EC . Astrocyte-specific expression
patterns associated with the PDGF-induced glioma microenvironment. _PloS one_ 2012; 7: e32453. Article CAS Google Scholar * Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC .
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. _Cancer Res_ 2004; 64: 4783–4789. Article CAS Google Scholar * Ciznadija D, Liu Y, Pyonteck SM, Holland
EC, Koff A . Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma. _Cancer Res_ 2011; 71: 6174–6183. Article CAS Google Scholar * Hukkelhoven E, Liu Y,
Yeh N, Ciznadija D, Blain SW, Koff A . Tyrosine phosphorylation of p21 facilitates the development of proneural glioma. _J Biol Chem_ 2012; 287: 38523–38530. Article CAS Google Scholar *
Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R _et al_. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). _EMBO J_ 2007; 26:
4683–4693. Article CAS Google Scholar * See WL, Heinberg AR, Holland EC, Resh MD . p27 deficiency is associated with migration defects in PDGF-expressing gliomas _in vivo_. _Cell Cycle_
2010; 9: 1562–1567. Article CAS Google Scholar * See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A . Defective DNA double-strand break repair underlies enhanced tumorigenesis and
chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. _Oncogene_ 2010; 29: 1720–1731. Article CAS Google Scholar * Cerami E, Demir E, Schultz N,
Taylor BS, Sander C . Automated network analysis identifies core pathways in glioblastoma. _PloS one_ 2010; 5: e8918. Article Google Scholar * Cheung CC, Yang C, Berger T, Zaugg K, Reilly
P, Elia AJ _et al_. Identification of BERP (brain-expressed RING finger protein) as a p53 target gene that modulates seizure susceptibility through interacting with GABA(A) receptors. _Proc
Natl Acad Sci USA_ 2010; 107: 11883–11888. Article CAS Google Scholar * Aktas H, Cai H, Cooper GM . Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin
D1 and the Cdk inhibitor p27KIP1. _Mol Cell Biol_ 1997; 17: 3850–3857. Article CAS Google Scholar * Yan Q, Sun W, Kujala P, Lotfi Y, Vida TA, Bean AJ . CART: an Hrs/actinin-4/BERP/myosin
V protein complex required for efficient receptor recycling. _Mol Biol Cell_ 2005; 16: 2470–2482. Article CAS Google Scholar * Abbas T, Dutta A . p21 in cancer: intricate networks and
multiple activities. _Nat Rev Cancer_ 2009; 9: 400–414. Article CAS Google Scholar * Broxmeyer HE . Enhancing engraftment of cord blood cells via insight into the biology of
stem/progenitor cell function. _Ann N Y Acad Sci_ 2012; 1266: 151–160. Article CAS Google Scholar * Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M _et al_. A critical role
for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. _Proc Natl Acad Sci USA_ 2004; 101: 17204–17209. Article CAS Google Scholar * Lee J, Kim SS . The function of p27 KIP1
during tumor development. _Exp Mol Med_ 2009; 41: 765–771. Article CAS Google Scholar * Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR _et al_. ErbB2/Neu-induced,
cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. _Mol Cell Biol_ 2002; 22: 2204–2219. Article CAS Google
Scholar * Viglietto G, Motti ML, Fusco A . Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. _Cell Cycle_ 2002; 1: 394–400. Article CAS Google Scholar *
Aaltomaa S, Lipponen P, Eskelinen M, Ala-Opas M, Kosma VM . Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. _Prostate_ 1999; 39: 8–15. Article CAS Google
Scholar * Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS _et al_. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
_Gynecol Oncol_ 2001; 81: 341–347. Article CAS Google Scholar * Baretton GB, Klenk U, Diebold J, Schmeller N, Lohrs U . Proliferation- and apoptosis-associated factors in advanced
prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. _Br J Cancer_ 1999; 80: 546–555. Article CAS Google Scholar *
Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G _et al_. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast
carcinomas with different prognostic indicators. _Int J Cancer_ 2001; 95: 128–134. Article CAS Google Scholar * Cheung TH, Lo KW, Yu MM, Yim SF, Poon CS, Chung TK _et al_. Aberrant
expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma. _Cancer Lett_ 2001; 172: 93–98. Article CAS Google Scholar * Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De
Pasqua A _et al_. p21WAF1/CIP1 protein expression in primary ovarian cancer. _Int J Oncol_ 2000; 17: 1231–1235. CAS PubMed Google Scholar * Sarbia M, Gabbert HE . Modern pathology:
prognostic parameters in squamous cell carcinoma of the esophagus. _Recent Results Cancer Res_ 2000; 155: 15–27. Article CAS Google Scholar * Winters ZE, Leek RD, Bradburn MJ, Norbury CJ,
Harris AL . Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis. _Breast Cancer Res_ 2003; 5: R242–R249. Article
CAS Google Scholar * James MK, Ray A, Leznova D, Blain SW . Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. _Mol Cell Biol_ 2008; 28: 498–510.
Article CAS Google Scholar * Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L _et al_. The tripartite motif family identifies cell compartments. _EMBO J_ 2001; 20: 2140–2151.
Article CAS Google Scholar * Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D _et al_. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific
MDM2 signaling. _Cell_ 2009; 137: 1018–1031. Article CAS Google Scholar * Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C _et al_. Cooperation between p27 and p107
during endochondral ossification suggests a genetic pathway controlled by p27 and p130. _Mol Cell Biol_ 2007; 27: 5161–5171. Article CAS Google Scholar * Taylor BS, Barretina J, Socci ND,
Decarolis P, Ladanyi M, Meyerson M _et al_. Functional copy-number alterations in cancer. _PloS one_ 2008; 3: e3179. Article Google Scholar Download references ACKNOWLEDGEMENTS We thank
Marta Kovatcheva and other members of the Koff lab, Pengbo Zhou (Cornell University Medical School), John Petrini (MSKCC) and Hakim Djaballah (MSKCC) for comments on this manuscript, and Max
Chan Liu (The Browning School) for his assistance with Id1 staining and image acquisition. This work was supported by the Memorial Sloan-Kettering Cancer Center Core Grant (P30CA08748) and
grants to Andrew Koff (CA89563). Funding was also provided by the Brain Tumor Center (YL, DC) and the Golfers Against Cancer Foundation (AK). _Author contributions:_ YL carried out the
experiments identifying TRIM3 and measuring the effect of manipulating TRIM3 on p21 in cells. AMP, TO, NPG, CB and ECH analyzed TRIM3 expression in human tumors and human tumor extract. RR,
NY, DC, EH, HEB and PT provided experimental assistance or reagents throughout the course of this work. AK directed the research. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Programs in
Molecular Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA Y Liu, R Raheja, N Yeh, D Ciznadija, E Hukkelhoven, H Erdjument-Bromage, P Tempst & A Koff * Human Oncology
and Pathogenesis, New York, NY, USA A M Pedraza & C Brennan * Cancer Biology, New York, NY, USA T Ozawa & E C Holland * Computational Biology. Memorial Sloan Kettering Cancer Center,
New York, NY, USA N P Gauthier Authors * Y Liu View author publications You can also search for this author inPubMed Google Scholar * R Raheja View author publications You can also search
for this author inPubMed Google Scholar * N Yeh View author publications You can also search for this author inPubMed Google Scholar * D Ciznadija View author publications You can also
search for this author inPubMed Google Scholar * A M Pedraza View author publications You can also search for this author inPubMed Google Scholar * T Ozawa View author publications You can
also search for this author inPubMed Google Scholar * E Hukkelhoven View author publications You can also search for this author inPubMed Google Scholar * H Erdjument-Bromage View author
publications You can also search for this author inPubMed Google Scholar * P Tempst View author publications You can also search for this author inPubMed Google Scholar * N P Gauthier View
author publications You can also search for this author inPubMed Google Scholar * C Brennan View author publications You can also search for this author inPubMed Google Scholar * E C Holland
View author publications You can also search for this author inPubMed Google Scholar * A Koff View author publications You can also search for this author inPubMed Google Scholar
CORRESPONDING AUTHOR Correspondence to A Koff. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS
ARTICLE CITE THIS ARTICLE Liu, Y., Raheja, R., Yeh, N. _et al._ TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1. _Oncogene_ 33, 308–315 (2014).
https://doi.org/10.1038/onc.2012.596 Download citation * Received: 07 August 2012 * Revised: 01 November 2012 * Accepted: 04 November 2012 * Published: 14 January 2013 * Issue Date: 16
January 2014 * DOI: https://doi.org/10.1038/onc.2012.596 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable
link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * glioma * p21 * PDGF * stem/progenitor *
TRIM3